William P. Kane Jr.
CIK: 0001813937
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LBRX
LB PHARMACEUTICALS INC
Director
Discretionary Trading P&L
Holdings
About Kane William P Jr
Kane William P Jr (SEC CIK 0001813937) files insider reports with the SEC as Director of LB PHARMACEUTICALS INC (LBRX).
Signal8 holds 3 ownership filings by Kane William P Jr (1 Form 3, 2 Form 4), filed between Sep 10, 2025 and Jun 5, 2026. Those filings report 2 transactions, from Sep 10, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kane William P Jr's filings is in NEW YORK, NY.
Recent filings by Kane William P Jr
Other insiders filing for LB PHARMACEUTICALS INC (LBRX)
- Miller Joseph M, Chief Financial Officer
- Kozauer Susan Gani, Chief Medical Officer
- Deep Track Biotechnology Master Fund, Ltd., 10% Owner
- RUFFOLO ROBERT R, Director
- Nussbaum Ran, Director
- Luse Rebecca, Director